当前位置: X-MOL 学术Microb. Pathog. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Use of Nasoill® via intranasal to control the harmful effects of Covid-19.
Microbial Pathogenesis ( IF 3.8 ) Pub Date : 2020-09-17 , DOI: 10.1016/j.micpath.2020.104504
Carlos Eduardo Cuevas-Barragan 1 , Marco Tulio Buenrostro-Nava 2 , Gabriela Monserrat Palos-Gómez 3 , Elisa Alejandra Ramirez-Padilla 2 , Blanca Isabel Mendoza-Macias 2 , Raymundo Rene Rivas-Caceres 4
Affiliation  

In the absence of vaccines and antiviral drugs available to prevent and treat COVID-19, it becomes imperative to find or use all those products with the potential to fight this virus. This article is an attempt to propose ways to prevent, treat and control the COVID-19 virus, using a product based on plant extracts with the potential to reduce the symptoms caused by the SARS-CoV-2 virus. Nasoil® counts as one of its main components, Asclepias curassavica extracts, and in the present study it has been shown that it is an effective adjuvant in the treatment of Covid-19, increasing the respiratory capacity of the patients (SpO2> 90%) and reducing the symptoms from the first application, improving the patients around the fifth to the eighth application. At a preventive level, the individuals in this study who have applied it (400 individuals) only a 3.15% of these presented symptoms, disappearing when increasing the weekly applications.



中文翻译:

通过鼻内使用 Nasoill® 来控制 Covid-19 的有害影响。

在没有可用于预防和治疗 COVID-19 的疫苗和抗病毒药物的情况下,寻找或使用所有这些有可能对抗这种病毒的产品就变得势在必行。本文试图提出预防、治疗和控制 COVID-19 病毒的方法,使用一种基于植物提取物的产品,该产品有可能减轻 SARS-CoV-2 病毒引起的症状。Nasoil® 算作其主要成分之一,Asclepias curassavica提取物,在本研究中,它已被证明是治疗 Covid-19 的有效佐剂,增加患者的呼吸能力 (SpO2> 90%) 并减少首次应用的症状,改善患者大约第五到第八次申请。在预防层面,本研究中应用它的个体(400 人)中只有 3.15% 出现症状,随着每周应用量的增加而消失。

更新日期:2020-09-24
down
wechat
bug